Ignite Creation Date:
2024-05-06 @ 2:09 AM
Last Modification Date:
2024-10-26 @ 11:14 AM
Study NCT ID:
NCT01983501
Status:
COMPLETED
Last Update Posted:
2020-09-21
First Post:
2013-10-28
Brief Title:
A Study of Tucatinib ONT-380 Combined With Ado-trastuzumab Emtansine T-DM1 in Patients With HER2 Breast Cancer
Sponsor:
Seagen Inc
Organization:
Seagen Inc
Key Dates - Follows AllAPIJSON File Order
Start Date:
2014-02-28
Start Date Type:
ACTUAL
Primary Completion Date:
2017-10-10
Primary Completion Date Type:
ACTUAL
Completion Date:
2020-09-03
Completion Date Type:
ACTUAL
First Submit Date:
2013-10-28
First Submit QC Date:
November 7 2013
Study First Post Date:
2013-11-14
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-09-17
Last Update Post Date:
2020-09-21
Last Update Post Date Type:
ACTUAL